• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人多能基质细胞(MSCs)可增加亨廷顿病转基因小鼠模型纹状体的神经发生并减少萎缩。

Human multipotent stromal cells (MSCs) increase neurogenesis and decrease atrophy of the striatum in a transgenic mouse model for Huntington's disease.

机构信息

Yerkes National Primate Research Center, Atlanta, Georgia, United States of America.

出版信息

PLoS One. 2010 Feb 22;5(2):e9347. doi: 10.1371/journal.pone.0009347.

DOI:10.1371/journal.pone.0009347
PMID:20179764
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2825266/
Abstract

BACKGROUND

Implantation of human multipotent stromal cells from bone marrow (hMSCs) into the dentate gyrus of the hippocampus of mice was previously shown to stimulate proliferation, migration and neural differentiation of endogenous neural stem cells. We hypothesized that hMSCs would be beneficial in a mouse model of Huntington disease (HD) due to these neurogenic effects.

RESULTS

We implanted hMSCs into the striatum of transgenic mice (N171-82Q) that are a model for HD. The implanted hMSCs rapidly disappeared over 3 to 15 days. However, they increased proliferation and neural differentiation of endogenous neural stem cells for up to 30 days. They also increased neurotrophic signaling and decreased atrophy of the striatum in 3-month old HD mice implanted with hMSCs one month earlier.

CONCLUSIONS

The results therefore suggested that neural implantation of hMSCs may be of benefit in HD but a number of parameters of dose, treatment schedule, and route of administration need to be optimized.

摘要

背景

先前的研究表明,将骨髓来源的人多能基质细胞(hMSCs)植入小鼠海马齿状回中,可刺激内源性神经干细胞的增殖、迁移和神经分化。我们假设由于这些神经生成作用,hMSCs 在亨廷顿病(HD)的小鼠模型中可能有益。

结果

我们将 hMSCs 植入 HD 模型(N171-82Q)转基因小鼠的纹状体中。植入的 hMSCs 在 3 至 15 天内迅速消失。然而,它们在长达 30 天的时间内增加了内源性神经干细胞的增殖和神经分化。它们还增加了神经营养信号,并减少了植入 hMSCs 一个月前的 3 个月大的 HD 小鼠纹状体的萎缩。

结论

因此,研究结果表明,hMSCs 的神经植入可能对 HD 有益,但需要优化剂量、治疗方案和给药途径等多个参数。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03d4/2825266/d0d13eefbeb3/pone.0009347.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03d4/2825266/5cec34fc2b87/pone.0009347.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03d4/2825266/b18e60aa116d/pone.0009347.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03d4/2825266/9ec33c7a97dc/pone.0009347.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03d4/2825266/a304d443a3da/pone.0009347.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03d4/2825266/d0d13eefbeb3/pone.0009347.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03d4/2825266/5cec34fc2b87/pone.0009347.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03d4/2825266/b18e60aa116d/pone.0009347.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03d4/2825266/9ec33c7a97dc/pone.0009347.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03d4/2825266/a304d443a3da/pone.0009347.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03d4/2825266/d0d13eefbeb3/pone.0009347.g005.jpg

相似文献

1
Human multipotent stromal cells (MSCs) increase neurogenesis and decrease atrophy of the striatum in a transgenic mouse model for Huntington's disease.人多能基质细胞(MSCs)可增加亨廷顿病转基因小鼠模型纹状体的神经发生并减少萎缩。
PLoS One. 2010 Feb 22;5(2):e9347. doi: 10.1371/journal.pone.0009347.
2
FGF-2 promotes neurogenesis and neuroprotection and prolongs survival in a transgenic mouse model of Huntington's disease.在亨廷顿舞蹈症转基因小鼠模型中,成纤维细胞生长因子-2(FGF-2)可促进神经发生和神经保护,并延长生存期。
Proc Natl Acad Sci U S A. 2005 Dec 13;102(50):18189-94. doi: 10.1073/pnas.0506375102. Epub 2005 Dec 2.
3
Ex vivo delivery of GDNF maintains motor function and prevents neuronal loss in a transgenic mouse model of Huntington's disease.外源性给予 GDNF 可维持亨廷顿病转基因小鼠模型的运动功能并防止神经元丢失。
Exp Neurol. 2010 Jul;224(1):155-62. doi: 10.1016/j.expneurol.2010.03.005. Epub 2010 Mar 19.
4
Preconditioning mesenchymal stem cells with the mood stabilizers lithium and valproic acid enhances therapeutic efficacy in a mouse model of Huntington's disease.用情绪稳定剂锂盐和丙戊酸预处理间充质干细胞可增强亨廷顿舞蹈病小鼠模型的治疗效果。
Exp Neurol. 2016 Jul;281:81-92. doi: 10.1016/j.expneurol.2016.04.003. Epub 2016 Apr 13.
5
Time of transplantation and cell preparation determine neural stem cell survival in a mouse model of Huntington's disease.移植时间和细胞制备决定亨廷顿舞蹈病小鼠模型中神经干细胞的存活。
Exp Brain Res. 2007 Mar;177(4):458-70. doi: 10.1007/s00221-006-0689-y. Epub 2006 Sep 30.
6
Xenotransplantation of human adipose derived mesenchymal stem cells in a rodent model of Huntington's disease: motor and non-motor outcomes.人类脂肪来源间充质干细胞在亨廷顿病啮齿动物模型中的异种移植:运动和非运动结果
Neurol Res. 2015 Apr;37(4):309-19. doi: 10.1179/1743132814Y.0000000456. Epub 2014 Nov 7.
7
Ectopic expression of the striatal-enriched GTPase Rhes elicits cerebellar degeneration and an ataxia phenotype in Huntington's disease.纹状体丰富的 GTPase Rhes 的异位表达会引起亨廷顿病的小脑变性和共济失调表型。
Neurobiol Dis. 2015 Oct;82:66-77. doi: 10.1016/j.nbd.2015.05.011. Epub 2015 Jun 3.
8
Stem cell factor and mesenchymal and neural stem cell transplantation in a rat model of Huntington's disease.干细胞因子与间充质及神经干细胞移植在亨廷顿舞蹈病大鼠模型中的应用
Mol Cell Neurosci. 2008 Mar;37(3):454-70. doi: 10.1016/j.mcn.2007.11.001. Epub 2007 Nov 12.
9
ESC-Derived BDNF-Overexpressing Neural Progenitors Differentially Promote Recovery in Huntington's Disease Models by Enhanced Striatal Differentiation.源自胚胎干细胞且过表达脑源性神经营养因子的神经祖细胞通过增强纹状体分化,在亨廷顿舞蹈病模型中对恢复产生不同程度的促进作用。
Stem Cell Reports. 2016 Oct 11;7(4):693-706. doi: 10.1016/j.stemcr.2016.08.018. Epub 2016 Sep 29.
10
Reduction in subventricular zone-derived olfactory bulb neurogenesis in a rat model of Huntington's disease is accompanied by striatal invasion of neuroblasts.在亨廷顿舞蹈病大鼠模型中,脑室下区源性嗅球神经发生的减少伴随着神经母细胞向纹状体的侵袭。
PLoS One. 2015 Feb 26;10(2):e0116069. doi: 10.1371/journal.pone.0116069. eCollection 2015.

引用本文的文献

1
Age-Related Neurodegenerative Diseases: A Stem Cell's Perspective.年龄相关性神经退行性疾病:干细胞视角
Cells. 2025 Feb 27;14(5):347. doi: 10.3390/cells14050347.
2
Advances in Stem Cell Therapy for Huntington's Disease: A Comprehensive Literature Review.亨廷顿舞蹈症干细胞治疗进展:一项全面的文献综述
Cells. 2025 Jan 3;14(1):42. doi: 10.3390/cells14010042.
3
Recent advances in stem cell therapy: efficacy, ethics, safety concerns, and future directions focusing on neurodegenerative disorders - a review.干细胞治疗的最新进展:疗效、伦理、安全问题以及聚焦神经退行性疾病的未来方向——综述

本文引用的文献

1
Stem/progenitor cells from bone marrow decrease neuronal death in global ischemia by modulation of inflammatory/immune responses.骨髓来源的干细胞通过调节炎症/免疫反应减少全脑缺血中的神经元死亡。
Proc Natl Acad Sci U S A. 2008 Sep 23;105(38):14638-43. doi: 10.1073/pnas.0803670105. Epub 2008 Sep 15.
2
Towards a transgenic model of Huntington's disease in a non-human primate.迈向非人类灵长类动物亨廷顿舞蹈症转基因模型
Nature. 2008 Jun 12;453(7197):921-4. doi: 10.1038/nature06975. Epub 2008 May 18.
3
Systematic neuronal and muscle induction systems in bone marrow stromal cells: the potential for tissue reconstruction in neurodegenerative and muscle degenerative diseases.
Int J Surg. 2024 Oct 1;110(10):6367-6381. doi: 10.1097/JS9.0000000000001609.
4
Application of mesenchymal stem cells for neurodegenerative diseases therapy discovery.间充质干细胞在神经退行性疾病治疗探索中的应用。
Regen Ther. 2024 Oct 30;26:981-989. doi: 10.1016/j.reth.2024.09.014. eCollection 2024 Jun.
5
Advances in Gene and Cellular Therapeutic Approaches for Huntington's Disease.亨廷顿舞蹈症的基因与细胞治疗方法进展
Protein Cell. 2024 Aug 9. doi: 10.1093/procel/pwae042.
6
Therapeutic advances in neural regeneration for Huntington's disease.亨廷顿舞蹈症神经再生的治疗进展
Neural Regen Res. 2024 Sep 1;19(9):1991-1997. doi: 10.4103/1673-5374.390969. Epub 2023 Dec 15.
7
Mesenchymal stem cells for the treatment of cognitive impairment caused by neurological diseases.间充质干细胞治疗神经疾病引起的认知障碍。
Biotechnol Lett. 2022 Aug;44(8):903-916. doi: 10.1007/s10529-022-03274-7. Epub 2022 Jul 9.
8
Neurogenesis in aging and age-related neurodegenerative diseases.衰老和与年龄相关的神经退行性疾病中的神经发生。
Ageing Res Rev. 2022 Jun;78:101636. doi: 10.1016/j.arr.2022.101636. Epub 2022 Apr 29.
9
Mesenchymal Stem Cells for Neurological Disorders.间充质干细胞治疗神经系统疾病
Adv Sci (Weinh). 2021 Feb 24;8(7):2002944. doi: 10.1002/advs.202002944. eCollection 2021 Apr.
10
Regenerative Stem Cell Therapy for Neurodegenerative Diseases: An Overview.再生干细胞疗法治疗神经退行性疾病:概述。
Int J Mol Sci. 2021 Feb 22;22(4):2153. doi: 10.3390/ijms22042153.
骨髓基质细胞中的系统性神经元和肌肉诱导系统:在神经退行性疾病和肌肉退行性疾病中进行组织重建的潜力。
Med Mol Morphol. 2008 Mar;41(1):14-9. doi: 10.1007/s00795-007-0389-0. Epub 2008 May 11.
4
Mesenchymal stem cells as mediators of neural differentiation.间充质干细胞作为神经分化的介质。
Curr Stem Cell Res Ther. 2008 Jan;3(1):43-52. doi: 10.2174/157488808783489471.
5
Disparate host response and donor survival after the transplantation of mesenchymal or neuroectodermal cells to the intact rodent brain.将间充质细胞或神经外胚层细胞移植到完整的啮齿动物大脑后,宿主反应和供体存活情况存在差异。
Transplantation. 2007 Dec 15;84(11):1507-16. doi: 10.1097/01.tp.0000288185.09601.4d.
6
"Stemness" does not explain the repair of many tissues by mesenchymal stem/multipotent stromal cells (MSCs).“干性”并不能解释间充质干细胞/多能基质细胞(MSC)对许多组织的修复作用。
Clin Pharmacol Ther. 2007 Sep;82(3):241-3. doi: 10.1038/sj.clpt.6100313.
7
Higher levels of extroverted hostility detected in gene carriers at risk for Huntington's disease.在亨廷顿舞蹈症风险基因携带者中检测到更高水平的外向性敌意。
Biol Psychiatry. 2007 Dec 15;62(12):1347-52. doi: 10.1016/j.biopsych.2006.12.016. Epub 2007 Jul 5.
8
Bone marrow-derived mesenchymal stromal cells for the repair of central nervous system injury.用于修复中枢神经系统损伤的骨髓间充质基质细胞
Bone Marrow Transplant. 2007 Oct;40(7):609-19. doi: 10.1038/sj.bmt.1705757. Epub 2007 Jul 2.
9
A progressive and cell non-autonomous increase in striatal neural stem cells in the Huntington's disease R6/2 mouse.亨廷顿病R6/2小鼠纹状体神经干细胞的渐进性及细胞非自主性增加。
J Neurosci. 2006 Oct 11;26(41):10452-60. doi: 10.1523/JNEUROSCI.2850-06.2006.
10
Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement.定义多能间充质基质细胞的最低标准。国际细胞治疗协会立场声明。
Cytotherapy. 2006;8(4):315-7. doi: 10.1080/14653240600855905.